Guru Ownership Trend
Guru Analysis for Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $293.64 M.
Top institutional holders include Cliff Asness and Frank Sands.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $67.62 M net inflow during the quarter.
Recent activity highlights Jefferies Group who dramatically increased their stake. Conversely, Renaissance Technologies (RenTech) reduced exposure by 26.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Ultragenyx Pharmaceutical Inc. (RARE)
Major holders include Cliff Asness ($214.14 M), Frank Sands ($105.46 M), Jefferies Group ($31.04 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 11.19 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $67.62 M, with 2 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited RARE. The total reported sell value was $27.62 M.
Yes, 0 managers opened new positions in RARE, and 2 increased their existing holdings. The total reported buy value was $95.24 M.